Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001689375-23-000061
Filing Date
2023-09-06
Accepted
2023-09-06 17:07:32
Documents
1
Period of Report
2023-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_169403443743456.html 4  
1 FORM 4 wf-form4_169403443743456.xml 4 11626
  Complete submission text file 0001689375-23-000061.txt   13082
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address
Dowden Nathan J (Reporting) CIK: 0001873392 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 231240026